Original Research
Published on 30 Oct 2024
Integrated multi-level omics profiling of disulfidptosis identifis SPAG4 as an innovative immunotherapeutic target in glioblastoma
in Cancer Immunity and Immunotherapy

- 1,708 views
Original Research
Published on 30 Oct 2024
in Cancer Immunity and Immunotherapy
Review
Published on 30 Oct 2024
in Cancer Immunity and Immunotherapy
Review
Published on 30 Oct 2024
in Cancer Immunity and Immunotherapy
Case Report
Published on 30 Oct 2024
in Cancer Immunity and Immunotherapy
Mini Review
Published on 30 Oct 2024
in Cancer Immunity and Immunotherapy
Review
Published on 30 Oct 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 28 Oct 2024
in Cancer Immunity and Immunotherapy
Case Report
Published on 28 Oct 2024
in Cancer Immunity and Immunotherapy
Review
Published on 28 Oct 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 28 Oct 2024
in Cancer Immunity and Immunotherapy
Case Report
Published on 28 Oct 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 28 Oct 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 28 Oct 2024
in Cancer Immunity and Immunotherapy
Review
Published on 28 Oct 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 25 Oct 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 25 Oct 2024
in Cancer Immunity and Immunotherapy